BSE Live
Jan 01, 16:01Prev. Close
73.25
Open Price
72.11
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 01, 15:41Prev. Close
73.32
Open Price
71.50
Bid Price (Qty.)
73.02 (10)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Bal Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -9.08 | 4.41 | 8.45 | 8.59 | 5.18 | |
| Net CashFlow From Operating Activities | 21.57 | 9.10 | 12.57 | 6.36 | 1.28 | |
| Net Cash Used In Investing Activities | -3.16 | -9.53 | -15.59 | -7.96 | -13.73 | |
| Net Cash Used From Financing Activities | -19.94 | 0.05 | 3.53 | 1.74 | 12.38 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -1.52 | -0.38 | 0.51 | 0.15 | -0.07 | |
| Cash And Cash Equivalents Begin of Year | 2.20 | 2.58 | 2.07 | 4.46 | 4.54 | |
| Cash And Cash Equivalents End Of Year | 0.68 | 2.20 | 2.58 | 4.61 | 4.46 |
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y